wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52724810-9598344E-3A53-44E9-B75E-CFE37961FD8D
Q52724810-9598344E-3A53-44E9-B75E-CFE37961FD8D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52724810-9598344E-3A53-44E9-B75E-CFE37961FD8D
Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL.
P2860
Q52724810-9598344E-3A53-44E9-B75E-CFE37961FD8D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52724810-9598344E-3A53-44E9-B75E-CFE37961FD8D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c248de781521ba8d5e6e2da6fafcc75bf1e00ebc
P2860
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.